Debate โ€บ Legal ยท Last reviewed 2026-05-16

Legal cases

Key figures: see people register (Bell, Cass). Chronology: Bell 2020-12 ยท Court of Appeal 2021-09 ยท Skrmetti oral arguments 2024-12 ยท Skrmetti ruling 2025-06.

Summary

Adolescent gender care has been the subject of substantial legal proceedings since 2020. This page documents the main cases: Bell v Tavistock (UK, 2020/2021), Re Kelvin (Australia, 2017), AB v CD (UK, 2021) and United States v Skrmetti (US Supreme Court, decided June 2025). See also /protocol/informed-consent/ for the Dutch WGBO framework.

1. Bell v Tavistock (UK, 2020/2021)

The case Bell v Tavistock was brought by Keira Bell, a former GIDS patient who was prescribed puberty blockers as a teenager, went on to cross-sex hormones and began surgical treatment, and later regretted this. The High Court ruled in December 2020 that it was "highly unlikely" that a child under 13 could be competent to consent to GnRHa treatment.1 On 17 September 2021 the Court of Appeal allowed the Trust's appeal: the Divisional Court should not have made a declaration and given general guidance on competence at different ages in judicial review proceedings, and, following Gillick, it is for clinicians, not judges, to assess the capacity of under-16s to consent in individual cases (judgment summary). See also /international/united-kingdom/.

2. AB v CD (UK, 2021)

In AB v CD the High Court ruled that parents are competent to consent to GnRHa treatment for their child, even where the child would not be considered competent under Bell criteria.2

3. Re Kelvin (Australia, 2017)

Before Re Kelvin, Australian law required court authorisation for Stage 2 treatment (CSH). In Re Kelvin the Family Court of Australia ruled that such authorisation was no longer required where parents, child and treating clinicians agree.3 See also /international/australia/.

4. United States v Skrmetti (US, 2024โ€“2025)

On 4 December 2024 the US Supreme Court heard oral arguments in US v Skrmetti โ€” a challenge to Tennessee's SB1, which bans puberty blockers and hormones for minors when given to treat gender dysphoria or gender incongruence (opinion). On 18 June 2025 the Court ruled 6โ€“3 that the law does not violate the Equal Protection Clause: because it classifies by age and medical use rather than by sex or transgender status, only rational-basis review applies, under which the law survives.4 See also /international/united-states/.

See also

Footnotes

  1. Bell v Tavistock and Portman NHS Foundation Trust [2020] EWHC 3274 (Admin); [2021] EWCA Civ 1363.
  2. AB v CD & Tavistock and Portman NHS Foundation Trust [2021] EWHC 741 (Fam).
  3. Re Kelvin [2017] FamCAFC 258.
  4. United States v. Skrmetti, No. 23-477 (oral arguments 4 December 2024; decided 18 June 2025).

Keira Bell across the network

Other sites in this network also cover this topic: